WuXi Biologics: Planning to issue A shares to specific investors, change in controlling shareholders.

Watson Biotech announced that the company is planning to issue Class A shares to specific entities, which may result in a change in the company's ownership. The company's stock has been suspended from trading since March 17, 2026, with the expected suspension period not exceeding 2 trading days.